Editorial
doi: 10.1038/mt.2010.42.
Safer CARS
- PMID: 20357776
- PMCID: PMC2862533
- DOI: 10.1038/mt.2010.42
Item in Clipboard
Editorial
Safer CARS
Mol Ther.
2010 Apr.
No abstract available
Comment in
-
Is it safer CARs that we need, or safer rules of the road?Mol Ther. 2010 Oct;18(10):1742-3. doi: 10.1038/mt.2010.162. Mol Ther. 2010. PMID: 20885432 Free PMC article. No abstract available.
Comment on
-
Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2.Mol Ther. 2010 Apr;18(4):843-51. doi: 10.1038/mt.2010.24. Epub 2010 Feb 23. Mol Ther. 2010. PMID: 20179677 Free PMC article.
-
Treatment of chronic lymphocytic leukemia with genetically targeted autologous T cells: case report of an unforeseen adverse event in a phase I clinical trial.Mol Ther. 2010 Apr;18(4):666-8. doi: 10.1038/mt.2010.31. Mol Ther. 2010. PMID: 20357779 Free PMC article. No abstract available.
Similar articles
-
Is it safer CARs that we need, or safer rules of the road?Mol Ther. 2010 Oct;18(10):1742-3. doi: 10.1038/mt.2010.162. Mol Ther. 2010. PMID: 20885432 Free PMC article. No abstract available.
-
The promise and potential pitfalls of chimeric antigen receptors.Curr Opin Immunol. 2009 Apr;21(2):215-23. doi: 10.1016/j.coi.2009.02.009. Epub 2009 Mar 25. Curr Opin Immunol. 2009. PMID: 19327974 Free PMC article. Review.
-
Armed T cells with CAR for cancer immunotherapy.Sci China Life Sci. 2016 Apr;59(4):331-2. doi: 10.1007/s11427-016-5047-0. Epub 2016 Apr 15. Sci China Life Sci. 2016. PMID: 27080712 No abstract available.
-
CD3ζ-based chimeric antigen receptors mediate T cell activation via cis- and trans-signalling mechanisms: implications for optimization of receptor structure for adoptive cell therapy.Clin Exp Immunol. 2014 Feb;175(2):258-67. doi: 10.1111/cei.12216. Clin Exp Immunol. 2014. PMID: 24116999 Free PMC article.
-
Chimeric Antigen Receptor T Cells and Hematopoietic Cell Transplantation: How Not to Put the CART Before the Horse.Biol Blood Marrow Transplant. 2017 Feb;23(2):235-246. doi: 10.1016/j.bbmt.2016.09.002. Epub 2016 Sep 13. Biol Blood Marrow Transplant. 2017. PMID: 27638367 Free PMC article. Review.
Cited by
-
Roadblocks to success for RNA CARs in solid tumors.Oncoimmunology. 2015 Jan 7;3(12):e962974. doi: 10.4161/21624011.2014.962974. eCollection 2014 Dec. Oncoimmunology. 2015. PMID: 25964863 Free PMC article.
-
Impact of T cell selection methods in the success of clinical adoptive immunotherapy.Cell Mol Life Sci. 2014 Apr;71(7):1211-24. doi: 10.1007/s00018-013-1463-5. Cell Mol Life Sci. 2014. PMID: 24077876 Free PMC article.
-
A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacy.Oncotarget. 2017 Jul 12;8(51):89256-89268. doi: 10.18632/oncotarget.19204. eCollection 2017 Oct 24. Oncotarget. 2017. PMID: 29179517 Free PMC article.
-
Infusing CD19-directed T cells to augment disease control in patients undergoing autologous hematopoietic stem-cell transplantation for advanced B-lymphoid malignancies.Hum Gene Ther. 2012 May;23(5):444-50. doi: 10.1089/hum.2011.167. Epub 2012 Jan 17. Hum Gene Ther. 2012. PMID: 22107246 Free PMC article. Clinical Trial.
-
Passive immunotherapeutic strategies for the treatment of malignant gliomas.Neurosurg Clin N Am. 2012 Jul;23(3):481-95. doi: 10.1016/j.nec.2012.04.008. Neurosurg Clin N Am. 2012. PMID: 22748660 Free PMC article. Review.
References
-
- Sadelain M, Riviere I., and , Brentjens R. Targeting tumours with genetically enhanced T lymphocytes. Nat Rev Cancer. 2003;3:35–45. - PubMed
-
- Lamers CH, Sleijfer S, Vulto AG, Kruit WH, Kliffen M, Debets R, et al. Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience. J Clin Oncol. 2006;24:e20–e22. - PubMed
-
- Maher J, Brentjens RJ, Gunset G, Riviere I., and , Sadelain M. Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta/CD28 receptor. Nat Biotechnol. 2002;20:70–75. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
